A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Wake Forest University Health Sciences
UNC Lineberger Comprehensive Cancer Center
Neonc Technologies, Inc.
NRG Oncology
University of Chicago